NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 60.28

+6.3%

11:50 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	1/9/2006 8:09:47 PM
	Read Replies (1) of 507

Cramer on NKTR ... Nektar Therapeutics (NKTR:Nasdaq - commentary - research - Cramer's Take): "I think you got 3 more points before you ring the register. Do you mind if I be a little bit piggish and let that stock run?" and some other comments ... Genentech (DNA:NYSE - commentary - research - Cramer's Take): "I need to see 36 cents [in EPS] . I need to see Avastin used for other purposes. ... Do you mind if I see the quarter? (Genentech reports earnings Tuesday). Amgen (AMGN:Nasdaq - commentary - research - Cramer's Take): "Seems to be stalled here. I have always said when Amgen is stalled it is time to do a 'mon back." thestreet.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next